| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 8 |
| 1 | BEVACIZUMAB | 6 |
| 2 | RITUXIMAB | 6 |
| 3 | CYCLOPHOSPHAMIDE | 5 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 5 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 5 |
| 6 | FLUOROURACIL | 5 |
| 7 | FLUOROURACIL CREAM, 0.5% | 5 |
| 8 | PREDNISONE | 4 |
| 9 | APIXABAN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | URIDINE TRIACETATE | 1 | 0.0067 |
| 1 | CALCIUM FOLINATE | 2 | 0.0004 |
| 2 | EDOXABAN TOSYLATE | 2 | 0.0003 |
| 3 | BENDAMUSTINE HCL | 2 | 0.0001 |
| 4 | OXALIPLATIN | 8 | 0.0001 |
| 5 | VINCRISTINE SULFATE | 3 | 0.0001 |
| 6 | SODIUM BICARBONATE INJECTION, | 2 | 0.0001 |
| 7 | BASILIXIMAB | 1 | 0.0001 |
| 8 | NYSTATIN OINTMENT | 2 | 0.0001 |
| 9 | NYSTATIN CREAM | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Polyene Antifungal [EPC] | 2 | 0.0000 |
| 1 | Platinum-based Drug [EPC] | 10 | 0.0000 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 6 | 0.0000 |
| 4 | Cardiac Glycoside [EPC] | 2 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 6 | Prostaglandin Analog [EPC] | 2 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 6 | 0.0000 |
| 8 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |